Digoxin: Clues to a Threshold for This Last-Resort Drug
Dr De Ferrari provides details on a substudy of the ARISTOTLE trial that examined digoxin blood levels and mortality in patients with and without heart failure. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - April 10, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Apr 7 Cardiology News
Cost effects of risk-factor management in AF, apixaban costs vs warfarin, bioresorbable-scaffold woes, exercise as heart-failure therapy, and surgical left atrial appendage closure are discussed. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - April 7, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Implications of Subclinical Leaflet Thrombosis in TAVR/SAVR
Dr Makkar provides more insights from the SAVORY and RESOLVE registries on the phenomenon of bioprosthetic valve leaflet thrombosis seen on 4D CT. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - April 5, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Mar 31 Cardiology News
High-sensitivity troponin testing, dabigatran during AF ablation, valve-in-valve TAVR, Impella, and the ARNI valsartan/sacubitril ' s effect on HbA1c are discussed in this week ' s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 31, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Assessing Stroke Risk in Adult Congenital Heart Disease
Drs Lyle, Ammash, and McLeod discuss risk stratification for stroke in adults with complex congenital heart disease and how to choose between warfarin or the direct oral anticoagulants in the absence of data. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 27, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Mar 24 Cardiology News
2017 American College of Cardiology (ACC) sessions in review: PCSK9 inhibitors, bioresorbable stents, CTO-PCI procedures, subclinical leaflet thrombosis in tissue aortic valves, and NOACs feature. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 24, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Alt FOURIER: Diet and Exercise vs PCSK9i?
If Dr Walton-Shirley were designing the next trial on PCSK9 inhibitors, she ' d include a Mediterranean diet and exercise arm. She and Dr Mandrola ponder alternative uses of our healthcare dollars. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 24, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
FOURIER Presenter, Dr Marc Sabatine, Interviewed
Dr Mandrola gets the details on the PCSK9 inhibitor evolocumab, and asks the $64,000 (or is that $14,000) question about cost-effectiveness. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 24, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
FOURIER/EBBINGHAUS: So Far, So Good. But Can We Afford It?
Drs Harrington and Yancy review the efficacy and cognitive safety data for the PCSK9 inhibitor evolocumab, presented at the American College of Cardiology sessions. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 23, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Mar 17 Cardiology News
A post-PCI bleeding risk score, BMI and AF ablation, nonalcoholic fatty liver disease, sugary drinks, and upcoming studies at ACC are discussed in this week ' s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 17, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Mar 10 Cardiology News
Statins poststroke, advance directives, sleep disorders and ICD shocks, genetic test to gauge statin benefit, and NOACs in valvular disease are discussed by Dr John Mandrola in this week ' s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 10, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
The VA System: An Integrated Healthcare Example for All
The Veterans Health Administration is the largest integrated healthcare system in the US with a common EHR. Dr Harrington learns the advantages for cardiology practice and research. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 8, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Should Cost of Therapy Be Considered in CV Guidelines?
New cardio drugs, such as PCSK9 inhibitors and the angiotensin receptor neprilysin inhibitor, are expensive. Dr O ' Donoghue asks whether that should affect guideline recommendations. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 6, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
